ARCHIVES

Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML

This article is from The Cancer Letter archive.

Vol. 30 No. 12 | December 28, 2007

Download PDF Visit The Full Archive

Related Articles

Home Test Detects Hematuria Earlier

August 4, 1989

Broder’s Conundrum: How To Let Congress Know NCI Needs More Money Without Asking For it

March 17, 1989

OMB Budget Revision Would Cut Centers $20 Million, Slash Clinical Education, Training, Contracts Funds

April 22, 1983

In Brief: FDA Names DeLap Directory Of Oncology

June 7, 1996

UCSF Receives $125 Million Gift for Cancer Hospital

March 27, 2009

AACR Presents Awards at Annual Meeting

April 5, 2013